Market Overview

Regulus Therapeutics (NASDAQ: RGLS)

1.17 +0.05 (4.46%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/19/19MaintainsMarket Perform1.5
7/10/18DowngradesNeutral
7/06/18MaintainsNeutral0.500
7/06/18MaintainsMarket Perform1.0
3/28/18Initiates Coverage OnNeutral1.0
3/08/18MaintainsMarket Perform1.4
1/05/18Initiates Coverage OnOutperform2.0
11/08/17MaintainsMarket Perform1.0
8/02/17MaintainsMarket Perform1.2
8/02/17DowngradesNeutral

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter